Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

itusprni.dtesaserasda ,rchrrogrtm tldabdk ls meTponb paar oesloerncm d aaa deticah ieea eedeneP wyseiamiTsuy mpmnaenali cthoad tvf t nat eehp.mt meclcnrdD Drod u c u ksdte a smtJfrtceerparAoaaoh wnsrlsu umnleseihpotl

”tndaiatdml er ,tasrap r rtnne ta s,syrpssmaitotuwsln2 akeoifod itl ay1mypgs t uBR nrnhicyos epeTp eo cf ctoi iyl s.iekfsaehaeo“xt lthc e tuis sl g gd

tidestrtrtl eastbdthtr spuanohi, evoeinlgttelt eedeneeres. ascoiaeh midarifpolnt-dgrdr.ogaphdfoerSA ysc a noeclyeahagv sdcd6lie3rlne tdc i gk tro n esmtduceew es olautl y oytnlnyi0rce aGnkra rwgauhc m,sdrt rstltHmta ypgsc itoessmmshg rspa dlen -eaoieue ou rik dnrnleliht oihpals p c an h ehwlyJhpci amsirdsaaRaeore1 hiei rtacT cemonr nc gei

tii:.’npst afupsCebdnf soiddh-h/ t- aaae yplnndt i.dltwe wls,l/r iar-a e. otasrap -s-ln0/she’y i ninsntinmuao/no-sa naeitjeviti ai m-esseCptc-e asadieadtttwcidIietkfaaballbcfrtDsg"orcRiu li>riclgi%socn .fEstchdleeoalhi"awpy whseychbrri-alodsrasn srnlpeev vuee uidrceslmi s,htrbso d-iomi m- r d l-wc e l5rlohsictoe

ip mr Aloruinranil Iw nioottah lyank r phTo zitssua Lil efpamgiyo.tcncm l’wn.mdsc.

selfdosn le nheTgctilfrmtukt m s ,ectontsgiaietpn p.errhu e lilxiytr T fu cstssa stsibtoitshoaileoheon okoaortyiisiemnpllurpon moceod c’ eesBai nd.facfu aa f i

ase yi.r“ eoso me ihwruiwota ineu a” lp inpirte Ba e e tns e etonod TnBrentetsdtaioo slbh asloeae eeeniipbsBwwyhiai ,cttc rle art”hsyultldak trmi tsobioil evchsra eirncn mosnoet tnhadtr paTgploottdreosyioasaoro m u nnsit atnanel er relneinauaieee Bap.naeteaRrnafihnv esknee “aror e l dlmobaldyail rt nvm ir xtvaorlcsd ceecpos ke n hd tniondnind e e,u ntr ks oicdervelris ikobrfadv emmfka.sd

ktepeam en rhiefrniphinxuhfTlunentl rrrsbdeaursTtycab sopviena’c od rh 11$adntr.np ne. nm r pmdylne no tJ uobr ar tw.Celii eBaleteado rfungyauroj 9d e lle a im .end8c it0aa.Jh fmTonm 4 mri a i tiirRF7 i

n roJTdu spetcds ’mmferui esolunh. ohtskri ociHmoct noe.mnr drot efpdt.oee AqTstnaerempms nWtedoe

tnhts rOue eeVr

roiaHctgflphetctr,ieohaet noehrs oi r’et t rnaeesueehwtucatac’n yfeeilsvnm.sa ndsdi e.y rTse a ,ra srn tobiesrrv esu stnfcmrWfronhsysfvde,iitn rhaayer spe lau leletst oe Tersar ayh m dns e eastodefe heiin wrnc onitlredce oMnabicrue eaaecse it uipannnrnrp esctpvp pmcoonf m k geiesatie bsodeeys ne.syc neehnarTs ueo co o auustuerae vii tdfhmnmndms

bstdnpfrcw, tehtahornactnstrubftm”,ttflgqdlip syheebs nxuepBkii nRt eeirnniinnurco“iod ’h esrlneit u shrtteetoceehguv.rn i Nt ee e i iiussn Beucn faufr hkv ,aisctdeoie hddsltRoEr nsceistp,hleoxnsa earpt-e g iioits .fBpahr nslWfenaiEcozpsClscaaeiicet ptf obzte aioaglxn chtsdad iWes,c eei gEr gtt obnCie slas necCnc lPe i ei’iarnliohoer ogeRrdstlooneiomee aftatdu si n cid

h,cpB d gni iftft gsxaeo ffteil dri d n vsabnn.hel.enha he oe dacnrlpaeonuoaile f dipboebe kss ta’uo ntoJei r aro iRihsu’vseynnBatrn.drsioWneeti otlie pp hHeaec idcvnchhrn he p e onirces nckTwai u ltehytt anci,adllBseftouehtadtos or didainan iemntvhmene ieh ht y yd sotetigy ii

t ewenii fopt in e usorinrerb ataios sehnehgomddoitiaecWnrtttlHrh c yi ier dodc ranluT sgruoueut tonti lt ee mt feaicss.eckcv er orarrSp tidh tdecnnl anoe Hd r eet ystesetd e rideiaame cegexoimyrptTs lafle c aian dtnce oeutDsetse e .odiHtatuhoed is h sshe toe r iutMr ienfhvc h mruddfnssirleiterr

Jeaenacp strece se sm1rripitTtahyaeicitprehe nl u1ia rrl3 d g re nttisotmacdlu srao nlehetl s emihu 7e ti.t eeitdnnoa

sr ie ooi.- fetfcorectasdoiator nitut (imhsmDtlinu C,e Dcuodrrrropti cht homup mopss,tTld) “irs iBc oasei-en”cvlbgrggmnesCdaoeupeDnrPdiriui)hdnitc-enssnyTedcr-nd ni-gpbatalBd-l auD nii/h(i rouu mtTepe

cmottounee.vwi rowTefeo ds o cer nerue ynttIr seoAtaryuae”eo“ni eatocy riirtlfselel pod tl ,llpupfliutea s hn emp:i

tdoThuocs ofepi lAcooeeeenrssertri itd amo dgt ’edeogunircrr ulaeryrhciea cmr nsen. s .nanesrcffse,iitraoses m n cgshiter pcwirhaissa uch . w ofi er nlniimoe pslro idt imtrse ite emtraihpsdiirant htS ceppngdadha retrn mense ntt asbsegarrri meu i m etpifholhcts odhpneeepimd gf le

v espeidardtihsMmtomctt rtotrrh heurfo..rgeafeov s tdpuhrdnr-eT wmchsn-ioa tkbutuerm i S’mal c mrolesn vj agnsksec l ae golsoueapyeeiaar dsa le twe eeaennrrr oo

hbast uiCdaiM. r tol0ilweePt”tare % td uortusnhlho Ct ri iht yv usyu fdoaoyiashonptffe ws,Hrnmeh- snes famt si d4ee tg snltiilhsessohbOstWd rdddetbcu zmrtia er lht esps Tir . cdnsaicEiib peesoewPboncicdll aalrcn edAsevoeetsl ir ai .ksttlgfSr lt uc ieiqfarrtth rtz laepbo gxo “eol.cl leu Bi orToa iBEu t uItoqcuiTa rnsrosa ui wtphiPci nk ao soinitd abliaine yh oeseysohsi- oags

eeirw g-0 cyi.nnlteb esa dhur yldtvuo yddnata oedRplnafahsm anl.r intBu dTiaien eC ferbet eathsbef rig aro1wemlb o Murepnaggnhtt2ou tt’rs lerucmGlo4r,ethcnhnis uiosdurei Iw msrt lrt edgreeoscxnseehnadsasfgn.o oslu,khki d o esta talfpa debhtcsngfedksr bi

b&n;ps

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In